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Summary 
SRP-27 is a newly identified integral membrane protein constituent of the skeletal muscle 
sarcoplasmic reticulum We identified its primary structure from cDNA clones isolated from a 
mouse skeletal muscle cDNA library. ESTs of SRP-27 were found mainly in cDNA libraries from 
excitable tissues of mouse. Western blot analysis confirmed the expression of SRP-27 in skeletal 
muscle and to a lower extent in heart and brain. Mild trypsin proteolysis combined with primary 
structure prediction analysis, suggest that SRP-27 has 4 transmembrane spanning alpha helices and 
its  COOH-terminal domain faces the cytoplasmic side of the endo(sarco)plasmic reticulum. The 
expression of SRP-27 is higher in fast twitch skeletal muscles compared to slow twitch muscles and 
peaks during the first month of post-natal development. High resolution immunohistochemistry and 
western blot analysis of subcellular fractions indicate that SRP-27 is distributed in both longitudinal 
tubules and in terminal cisternae of the sarcoplasmic reticulum, as well as in the perinuclear 
membrane systems and the nuclear envelope of myotubes and adult fibers. SRP-27 co-sediments 
with the ryanodine receptor macromolecular complex in high salt sucrose gradient centrifugation, is 
pulled-down by anti-ryanodine receptor antibodies as well as by maurocalcin, a well characterized 
ryanodine receptor modulator. Our data indicate that SRP-27 is part of a sarcoplasmic reticulum 
supramolecular complex suggesting the involvement of SRP-27 in the structural organization or 
function of the molecular machinery underlying excitation-contraction coupling (226 words). 
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Introduction 
      The skeletal muscle sarcoplasmic reticulum (SR) is an intracellular membrane compartment that 
controls the myoplasmic calcium concentration and therefore plays a crucial role in excitation-
contraction (E-C) coupling [1-3]. E-C coupling occurs in the triad, an intracellular junction formed 
by the association of the transverse tubules and the SR terminal cisternae [2-4]. E-C coupling is 
initiated by conformational changes of the L-type voltage dependent Ca2+ channel (DHPR), the 
voltage sensor localised within the membrane of the T tubular system [4,5]. Activation of Ca2+ 
release from SR terminal cisternae is due to the direct transmission of conformational changes of 
DHPR to ryanodine receptors (RyR). This model implies a close association between the SR 
terminal cisternae and T tubular membrane, and as well as the two channels, DHPR and RyR [5-10]. 
Detailed analysis of highly purified triad membrane fractions revealed that their protein composition 
is quite complex.  The known protein components are: the SR Ca2+ release channel (RyR), the 
DHPR, the triadin, the histidine rich Ca2+ binding protein (HRCP), the 90 kDa JFP, calsequestrin, 
mitsugumins, junctophilin, JP45, junctate, the 32 kDa ADT/ATP carrier [11-21], and a number of 
other polypeptides corresponding to still unidentified proteins. Because of their localisation in the 
junctional sarcoplasmic reticulum membrane, these proteins are likely to play a role either in the 
organization of the triad during development or in the mechanism of signal transduction in skeletal 
muscle. In this study, we discovered a 27 kDa protein that we named SRP-27 (for sarcoplasmic 
reticulum protein-27 kDa). We show that this polypeptide is present in skeletal muscle sarcoplasmic 
reticulum membranes as well as in the nuclear/endo(sarco)plasmic reticulum membrane of excitable 
tissues including heart and brain. SRP-27 co-sediments with the RyR complex, and its level of 
expression depends on fiber type differentiation and on the development stage. 
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Experimental Procedures 
Materials 
Protein G-Sepharose, PCR primers, Peroxidase conjugated protein A, Protein-A Sepharose 
were from Sigma/Fluka; The pGEX-5X-3 plasmid, [35S]-methionine and Protein-A Sepharose were 
from Amersham Biosciences. The pEYFP-N1 plasmid was from Clontech. Nitrocellulose 
membrane was from Schleicher & Schuell BioScience GmbH. Protein Molecular Weight markers 
were from Biorad. All other chemicals were reagent or highest available grade. Rats (Wistar) were 
bred in house. Rabbits (NZW) were purchased from Charles Rivers Laboratories (Calco, Italy). All 
procedures were performed in accordance with the stipulations of the Helsinki Declarations for care 
and use of laboratory animals. 
 
Methods 
SRP-27 cDNA cloning 
Total RNA was isolated from rat limb skeletal muscles using Tri-Reagent (Molecular 
Research Center Inc.) following the instructions provided by the manufacturer. Total RNA was 
converted to cDNA using the cDNA Synthesis Kit from Roche Applied Science using a T17-
adapter primer 5'-GACTCGAGTCGACATCGAT(17) -3' in order to reverse transcribe mRNA and 
obtain cDNA with an adapted sequence in the 3' end compatible to perform 3'-RACE-PCR. All 
clones were sequenced (Microsynth AG, Balgach, Switzerland). The open reading frame cDNA of 
rat SRP-27 digested with EcoRI and XhoI was used as probe to screen a mouse skeletal muscle 
UNI-ZAP XR cDNA library as previously described [16]. A clone of 2123 bp, containing the entire 
ORF was pulled out and sequenced (Microsynth AG, Balgach, Switzerland)  
 
Immunohistochemistry 
Cryosections of mouse diaphragm muscle were immunostained as described in Flucher et al. 
[22]. Primary antibodies and working dilutions were: affinity-purified rabbit ant-SRP-27 (see 
below; 1:100); affinity-purified rabbit anti-RyR1 at (1:2,000)[22]; mouse monoclonal anti-panRyR 
(C-34, Alexis Co., Lausen, Switzerland; 1:1,000); mouse monoclonal anti-SERCA2a (MA3-911; 
Affinity Bio Reagents, Neshanic Station, NJ; 1:1,000); mouse monoclonal antibody against α-
actinin (1:1,000). Secondary antibodies: Alexa488- and Alexa595-conjugated goat-anti-rabbit and 
goat-anti-mouse IgG (Molecular Probes, Eugene, OR) used at dilutions of 1:4,000. Images were 
recorded on a Zeiss Axiophot microscope with a cooled CCD camera and METAVUE image-
processing software (Universal Imaging, West Chester, PA). 
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Western blots staining 
SDS-PAG electrophoresis and indirect immunoenzymatic staining were carried out as 
previously described [19]. Protein concentration was determined with the DC Protein Assay kit 
(Biorad) following the instruction provided by the manufacturer using bovine serum albumin as 
standard. 
 
Polyclonal antibody production. Details are described in the Supplementary figure 1.   
 
Subcellular fraction preparation. 
Total microsomes from different rat tissues (heart, lung, brain, kidney, skeletal muscle, liver, 
spleen, stomach, intestine) were prepared as previously described [16,19]. Rat skeletal muscle SR 
fractions were obtained as previously described [23]. 
 
Expression in COS-7 and TSA cells 
COS-7 cells were transfected with the SPR-27-pEYFP-N1 plasmid or the pEYFP-N1 
plasmid as previously described [19]. Transfected COS-7 cells were imaged 48 h after transfection 
with a Nikon Eclipse TE 2000-U inverted fluorescent microscope equipped with a 100x Plan-Apo 
oil immersion objective and using a D1 digital camera (Nikon Inc). TSA cells were transfected with 
the SRP-27-pEYFP-N1 plasmid or the pEYFP-N1 plasmid as control using calcium phosphate as 
previously described [19]. Cells were used 48h after transfection and the total microsomal fraction 
was prepared as described [19].  
 
Trypsin digestion 
Fifteen micrograms of protein were digested with increasing concentrations of trypsin, for 2 
minutes at room temperature. The reaction was blocked by adding soybean trypsin inhibitor and 
samples were analyzed by staining western blot with anti-GFP Ab BD-Living Colors A.v. Peptide 
Ab (Clontech) or anti-calreticulin Ab (Santa-Cruz).  
 
Sucrose gradient 
Vesicles derived from the rat skeletal muscle membrane heavy (R4) fractions were 
solubilized in the presence of 1 or 0.2 M NaCl, 1% CHAPS, 0.003% egg phosphatidylcholine (L-α-
Lecithin, Egg Yolk), 10 mM HEPES pH 7.4, 1 mM DTT and anti-protease, for 30 minutes at 4°C. 
Unsolubilized proteins were removed by centrifugation and soluble proteins were separated on a 5-
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20 % sucrose gradient by centrifugation at 25,000 rpm for 16 h in a SW40 Ti Beckmann rotor [11]. 
Fractions were collected and analyzed by SDS- PAG and immunoblot with anti-SRP27 Ab.  
  
Pull-down and co-immunoprecipitation experiments 
Proteins solubilized from the heavy SR R4 fractions (see above) were incubated with 
streptavidin polystyrene beads (Dynabeads M-280 Streptavidin, Dynal-Biotech) coated with 
biotinylated maurocalcine (40 µM) in PBS in the presence of anti-proteases and BSA (0.1 mg/ml). 
After incubation, the beads were collected, washed and the bound proteins were analyzed either by 
immunoblot or autoradiography.  
For co-immunoprecipitation experiments 1 mg of rat skeletal muscle heavy SR was 
solubilized (4°C, 30 min) in a buffer containing 1 % CHAPS, 0.2 M NaCl, 10 mM HEPES pH 7.4, 
0.003% lipids (L-α-Lecithin, Egg Yolk), 1 mM DTT and protease inhibitor cocktail in a final 
volume of 1ml. After centrifugation (30 min 100,000xg) solubilized proteins were diluted 10 times 
with 0.2M NaCl, HEPES 10 mM pH 7.4 and protease inhibitor cocktail and incubated for 2 hours at 
room temperature with ProteinA-Sepharose beads coated with anti-SRP-27 antibody (50 µg) or 
Protein-G-Sepharose beads coated with anti-RyR antibody (10 µg). Beads were then washed three 
times with PBS and the bound proteins were eluted with cracking buffer (6 M urea, 10 mM 
SodiumPhosphate pH 7.2, 1 % SDS, 1 % ß-mercaptoethanol). Proteins present in the void, last 
wash and bound to the beads were separated by SDS PAG and blotted onto nitrocellulose. 
 
In vitro transcription. 
In vitro transcription [24] was performed using the TnT quick coupled 
transcription/translation system (Promega, Madison, WI, U.S.A.) according to the manufacturer 
instructions. 
 
Statistical analysis and Software 
Statistical analysis was performed using the Sudent’s t test for unpaired samples; means 
were considered statistically significant when the P value was <0.05. Images were processed using 
Gimp 2.2.13, Corel Photopaint 6.0 software. Blast alignments were performed on the NCBI web 
site using BLAST 2.2.8 released and highest. Multiple sequence alignments were performed using 
the Clustal W algorithm available from the Swiss node of the European Molecular Biology 
Network. Transmembrane domain prediction was obtained using TMhMM 2.0 on the Biology 
Workbench web site [25, 26].  
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Results and Discussion  
The biochemical and molecular characterization of the proteins present in SR membrane is 
an important task for understanding the mechanisms underlying Ca2+ homoeostasis in skeletal 
muscle under normal and pathological conditions. To identify novel proteins of the skeletal muscle 
SR involved in E-C coupling we performed mass spectrometry analysis of the protein constituents 
of the junctional face membrane. Proteins of the junctional face membrane were separated on a 
SDS-PAGE and the bands corresponding to polypeptides having a molecular mass ranging from 10 
to 100 kDa were processed for electronspray mass spectrometry analysis. This approach allowed us 
to identify a 19 amino acid long peptide sequence from a band migrating as a single polypeptide 
chain of 27 kDa (Fig.1, Rabbit pep). Its primary sequence matched that of a hypothetical protein in 
the NCBI database. We named this novel SR protein SRP-27, for sarcoplasmic reticulum 27 kDa 
protein. EST encoding the predicted primary acid sequence of SPR-27 were then used to design 
PCR primers and to amplify a cDNA fragment from total rat mRNA which was used to i) screen a 
mouse skeletal muscle cDNA library and ii) to produce a recombinant fusion protein to be used as 
antigen to generate polyclonal antibodies against the COOH-terminal domain of SRP-27.   
 
cDNA cloning, sequence analysis and membrane topology of SRP-27. 
We isolated the full length SPR-27 rat cDNA and compared the deduced amino acid 
sequence with the peptide sequence obtained from the protein sequence of the rabbit skeletal muscle 
junctional face membrane (Fig.1). The rat cDNA contains an open reading frame of 891 bp 
corresponding to a 297 amino acid long polypeptide (rattus norvegicus NCBI accession number 
EF690436). The deduced primary sequence of mouse skeletal muscle SRP-27 (mus musculus NCBI 
accession number EF988666) predicts a protein of 298 amino acids with a molecular mass of 33 
kDa. The predicted NH2-terminal sequences of both rat and mouse SPR-27 are 84% identical to 
amino acid peptide sequence obtained from the 27 kDa protein of the rabbit junctional face 
membrane. Multiple sequence alignments reveal that the mouse skeletal muscle cDNA clone 
encodes a protein displaying 97% and 98% identity with rat and human SRP-27 (Fig. 1). 
Transmembrane domain prediction (TMhMM) reveals four putative transmembrane segments. 
Expression of SPR-27/pYEFP fusion protein in COS-7 cells revealed two patterns of 
subcellular distribution: in approx. 40% of the transfected cells (437/1026) the fluorescence pattern 
was typically localized to the endoplasmic reticulum, as revealed by the reticular fluorescence 
originating around the nuclear membrane and extending into the cytoplasm. While 57% (588/1026) 
of the transfected cells displayed large cisternae whose membranes are enriched in the YFP-tagged 
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SPR-27 (Fig. 2A, 2B). The exact nature of the stained cisternae is unknown; these structures may 
represent dilations of ER membrane induced by the over-expression of SRP-27. 
In order to determine if native SRP-27 present in skeletal muscle is an intrinsic membrane 
protein, we extracted SR membranes with Na2CO3 at pH 11. Figure 2C shows that after this 
treatment, SRP-27 is found in the insoluble membrane fraction indicating that it is an integral 
protein of sarco(endo)plasmic reticulum membranes. Interestingly, we also noticed that SRP-27 
tends to form homo-oligomers as indicated by the immunopositive band of approx. 55 kDa visible in 
figure 2 C lane 2. The immunospecificity of this band was verified by pre-adsorption of SRP-27 Ab 
with the GST-SRP-27 fusion protein. Under these conditions both the upper and lower bands 
disappear (not shown).  
The membrane topology of the COOH terminal domain of the expressed SRP-27-YFP 
protein was established by mild trypsin proteolytic treatment of the total microsomal fraction 
isolated from transfected TSA cells. Western blot staining with polyclonal anti-GFP Ab reveals that 
the 55 kDa recombinant SRP-27-YFP fusion protein is degraded at increasing trypsin concentrations 
(Fig 2D, left). In control experiments carried out under similar conditions, the immunoreactivity of 
YFP was destroyed [27] (Fig.2D, right), whereas the reactivity of the intralumenal protein 
calreticulin was unaltered (Fig. 2D, lower panel), indicating that trypsin was excluded from the 
lumenal space.  Thus, since the COOH terminal region of SRP-27 is degraded after trypsin 
digestion, it must be facing the cytoplasmic side of the endo(sarco)plasmic reticulum membrane.   
 
Tissue distribution and developmental expression of SRP-27. 
The tissue distribution of SRP-27 was investigated by western blot staining of proteins 
present in the microsomal fractions of different rat tissues, using polyclonal anti-SRP-27 Ab. Figure 
3A shows that the SRP-27 kDa immunoreactive band is found in total rat microsomal membranes 
isolated from excitable tissues such as heart (lane 1), brain (lane 3) and skeletal muscle (lane 5) but 
is absent from lung, kidney, spleen, liver, stomach and intestine.  
We also determined the pattern of developmental expression of SPR-27 in skeletal muscles. 
Its expression appears to be dependent on both the developmental stage and on the muscle fiber type. 
Indeed, the content of SRP-27 in the total miscrosomal fraction of skeletal muscles increases at day 
15 and peaks at approximately 1-2 months of post-natal development (Fig. 3B, 3C). Furthermore, 
SRP-27 expression is 5 to 6 fold higher in fast twitch muscles compared to slow twitch muscles 
(Fig.3D, 3E). The increase in the SRP-27 content during post-natal development and its fiber type 
specific expression, suggest that this protein may be important in the post-natal maturation of 
skeletal muscle membranes. Since the SR is morphologically and functionally sub-specialized, we 
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analyzed more precisely the subcellular distribution of SRP-27 within the SR membrane by a 
combination of biochemical and immunohistochemical techniques.  
 
Subcellular distribution of SPR-27 
Immunonocytochemistry (Fig. 4A and 4B) of muscle fibers from adult mouse diaphragm 
indicate that SPR-27 is highly concentrated in the perinuclear ER region (arrows) and to a lesser 
extent is localized throughout the muscle fibers. The distribution pattern of SRP-27 between the 
myofibrils is consistent with its localization in the SR. However, direct comparison of its staining 
pattern with that of the RyR1 indicates that the sarcomeric SRP-27 overlaps, but does not precisely 
co-localize with the RyR1. Double labeling of SRP-27, RyR1, or SERCA with α-actinin show that 
the band of the SRP-27-containing compartment is located over the I-band. There it partially 
overlaps with the RyR1-labeled triads and alternates with the dominant SERCA band corresponding 
to longitudinal SR at the A-band. Thus, SRP-27 appears to also localize in a separate 
subcompartment of the SR, which is adjacent to, but distinct from that containing RyR or SERCA. 
Corroborating observations were made by double immunofluorescence labeling of SRP-27 with RyR 
in cultured mouse myotubes (supplementary Fig. 2). Whereas RyR1 was localized predominantly in 
clusters in the periphery of myotubes, SRP-27 was found in a membrane system throughout the 
myotubes. In addition, it accumulated between the nuclei in the center of the myotubes and in the 
nuclear envelope, indicating high concentrations of SRP-27 are also in the ER. 
Western blot staining of SR fractions confirm data obtained by immunohistochemistry. SRP-
27 is distributed in light (R2) and heavy (R4) SR membrane fractions enriched in longitudinal SR 
membrane and in terminal cisternae (R4), respectively (Fig. 4C). The presence of SRP-27 around the 
Z line and in the membrane fractions corresponding to longitudinal SR and terminal cisternae, 
suggests that SRP-27 might be part of a macromolecular Ca2+ signaling complex involved in 
pumping Ca2+ back into the SR and/or in releasing it via the Ca2+ release channel to activate muscle 
contraction. To evaluate whether SRP-27 is involved in any aspect of SR Ca2+ handling, we 
analyzed its distribution after separation of the SR membrane proteins by sucrose density 
centrifugation. Terminal cisternae were solubilized in the presence of CHAPS (1%) and NaCl (1 M) 
and the solubilized proteins separated on a continuous sucrose gradient (5 to 20%). Western blot 
staining of the proteins from different fractions of the sucrose gradient with SRP-27 Ab (Figure 5 
lower panel) shows that an important fraction of SRP-27 migrates in an intermediate density fraction 
containing other major SR proteins such as SERCA and calsequestrin (Fig. 5 upper panel, CBB 
stained gel). Interestingly, a remarkable fraction of the SRP-27 is also found in the sucrose density 
gradient fractions enriched in RyR (asterisk). The distribution of SRP-27 in the density gradient was 
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found to depend on the ionic strength of the sucrose gradient buffer. At low ionic strength (200 mM 
NaCl) the content of SRP-27 in the intermediate density fraction (enriched in SERCA and 
calsequestrin) is negligible and the bulk of SRP-27 is found in the fractions corresponding to a 
sucrose concentration of 15-18%, which also contain the RyR complex (not shown). The presence of 
SRP-27 in these heavy sucrose fractions could result from the aggregation of SRP-27 leading to the 
formation of large complexes that co-sediment with the RyR complex. However, we think that it is 
unlikely since aggregation of at least 100 SRP-27 molecules would be required to form a 2.5 MDa 
complex able to co-migrate with the RyR complex. On the other hand, the presence of SRP-27 in the 
fraction enriched in RyR after solubilization in 1% CHAPS at low ionic strength, may suggest the 
existence of a macromolecular complex resulting from the direct or indirect association of SRP-27 
with the RyR complex. In order to assess the existence of such an association, we performed two 
sets of experiments; in the first, solubilized SR proteins were pulled down using beads coated with 
maurocalcine, a specific effector of RyR. As shown in figure 6A the RyR was found to interact with 
maurocalcine coated beads. In addition, maurocalcine coated beads also pulled-down SRP-27 (Fig. 
6A, right panel). Interestingly, SRP-27 obtained by in vitro translation was not pulled-down by 
maurocalcine coated beads (Figure 6B) indicating that SRP27 must bind to maurocalcine beads via 
another protein, most likely the RyR. In order to confirm that SRP-27 is part of a macromolecular 
complex containing the RyR, we performed co-immunoprecipitation experiments using anti-SRP27 
antibodies followed by western blot analysis using anti-RyR antibodies, or co-immunoprecipitation 
experiments using anti-RyR antibodies followed by western blot analysis using anti-SRP27 
antibodies. As shown in figure 6C these experiments clearly reveal the formation of a 
macromolecular complex formed by both SRP-27 and the RyR.  
In conclusion our results show that SRP-27 is widely distributed through muscle SR and ER, 
however, it also associates with the RyR, and thus is part of the sarcoplasmic reticulum 
macromolecular signaling complex .  
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Legends to Figures 
Figure 1. Predicted primary sequence of mouse SRP-27 and comparison with rat and human 
sequences. Black characters in grey boxes indicate conserved residues, white characters in dark 
grey boxes indicate non conserved residues. Putative transmembrane domains (TMhMM algorithm) 
are underlined in the mouse and rat sequences. Bold characters indicate the mass spec peptide 
sequence of rabbit junctional face membrane SRP-27. 
 
Figure 2. SRP-27 is targeted to ER/SR membranes. Panels A and B: COS-7 cells transfected 
with SRP-27-pEYFP-N1 cDNA show stack-like fluorescent bodies (A) or reticular fluorescence 
irradiating from the perinuclear region (B) (Bar 10 µm). Panel C: Microsomes from rat skeletal 
muscle (lanes 3 and 6) were treated with 100 mM Na2CO3  pH 11 to separate proteins loosely bound 
to membranes present in the supernatant (lanes 1 and 4) from integral membrane proteins (lanes 2 
and 5) Ten micrograms of protein were separated on 10% SDS-PAG and stained with Coomassie 
Brilliant Blue (lanes 1-3) or blotted onto nitrocellulose and probed with anti-SRP-27 antibody 
(lanes 4-6). Panel D: Crude microsomal fraction and the high speed supernatant were isolated from 
TSA cell transfected with SRP-27-YFP-N1 and the YFP constructs, respectively. 15 µg of protein 
were incubated with the indicated amounts of trypsin. After digestion, 11.25 µg protein were 
separated on a 12% SDS-PAG, blotted onto nitrocellulose and probed with anti-GFP antibodies. 
Lower panel shows the immunoreactivity with anti-calreticulin Ab, demonstrating that the vesicles 
were still intact after treatment with trypsin.  
 
Figure 3. Expression of SRP-27 in different tissues and during development. Panel A 
microsomal proteins from the indicated tissues (10 µg of skeletal muscle, 60 µg of all other tissues) 
were separated on a 10%SDS-PAG, blotted onto nitrocellulose and probed with anti-SRP-27 
antibody. Lane 1, heart; lane 2, lung; lane 3, brain; lane 4, kidney; lane 5, skeletal muscle; lane 6, 
liver; lane 7, spleen; lane 8, stomach; lane 9: intestine. Panels B and C: expression level of SRP-27 
during post-natal development: 10 µg of microsomal proteins obtained from rats of different ages 
(1day, 5 days; 10 days; 15 days; 1 month; 2 months) were separated on a 10 % SDS-PAG blotted 
onto nitrocellulose and stained with anti-SRP-27 antibodies (panel B). Panel C shows the 
densitometric analysis of the immunopositive bands. Values were normalised to the signal obtained 
from 2 month old rats (100%, bars represent mean± S.D., n=3). Panel D and E: SRP-27 is enriched 
in fast-twitch muscles. Ten µg of microsomal proteins obtained from Soleus and EDL muscles were 
separated on a 12% SDS-PAG blotted onto nitrocellulose and stained with anti-SRP-27 antibodies 
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(panel D). Panel E shows the densitometry analysis. Values were normalised to the EDL signal 
(100%, bars represent mean± S.D., n=3). 
  
Figure 4.  Subcellular localization of SRP-27 in the ER and SR of skeletal muscle fibers. Panel 
A: Double immunofluorescence labeling of SRP-27 (upper row and red in merged color image) and 
RyR1 (center row and green in merged color image) in mouse diaphragm muscle. SRP-27 is highly 
concentrated around myonuclei (arrows) and throughout the cytoplasm. In cross sections (left 
column) SRP-27 and RyR1 immunoreactivity is localized between the myofibrils (merged color 
image shows detail indicated above). In longitudinal sections (center and right columns) the SRP-27 
labeling pattern forms fuzzy cross bands (arrowheads), which overlap, but are distinct from the 
double rows of triads labeled with the RyR1 (B, fluorescent bead used for alignment of frames). 
Panel B: Double labeling of SRP-27, RyR1, or SERCA (upper row and green in the merged color 
image) with α-actinin (center row and green in merged color image) in longitudinal sections of 
mouse diaphragm muscle. SRP-27 and the markers for junctional and longitudinal SR show clearly 
distinct sarcomeric banding patterns (compare the 2.5x magnified insets). The vesicular structures 
containing SRP-27 are localized along the I-bands, whereas RyR1 is found on either side of the Z-
line and the dominant SERCA band over the A-band. SRP-27 and RyR1 are found in all fibers, 
whereas slow muscle fibers (*) are not stained with the SERCA2a antibody. (Bar, 10µm). Panel C: 
Localisation of SRP-27 in sarcotubular membrane fractions (R1-fraction enriched in light 
sarcoplasmic reticulum; R2- fraction enriched in longitudinal sarcoplasmic reticulum; R3- fraction 
containing a mixture of longitudinal sarcoplasmic reticulum and terminal cisterane; R4-fraction 
enriched in terminal cisternae): 10 µg of protein from sarcotubular membrane fraction were 
separated on a 12% SDS-PAG, blotted onto nitrocellulose and stained with anti-SRP-27 antibodies.  
Images were processed using The Gimp 2.2.13 
 
 
Figure 5. SRP-27 co-sediments with the RyR1 on a sucrose gradient. 1 mg of protein from rat 
skeletal muscle terminal cisternae were solubilized with CHAPS 1%, 1M NaCl as described in 
experimental procedures. Solubilized proteins were separated on a continuous sucrose gradient and 
fractions of 15 drops were collected. Forty five µl of each fraction were separated on a 6% (upper 
panel) or 12% (lower panel) SDS-PAG.  Proteins were stained with Coomassie Brilliant Blue 
(upper panel); arrows indicate CaATPase (SERCA), calsequestrin (CS) and the ryanodine receptor 
(RyR). The lower panel depicts the immunoblot stained with anti-SRP-27 antibodies. *shows 
fractions in which SRP-27 and the RyR co-sediment.  
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Figure 6. SRP-27 is part of the RYR macromolecular complex. Panel A: heavy SR vesicles 
were solubilized with 1% CHAPS, 0.2 M NaCl. The solubile proteins were incubated with beads 
coated with maurocalcine. Proteins present in the void (lane 1,3), last wash (lane 2,4) and bound to 
maurocalcine beads (lane 3,5) were stained with anti-RyR (left panel) and anti-SRP27 antibodies 
(right panel). Panel B: [35S] labelled SRP-27 was obtained by in vitro translation. The labelled 
protein was incubated with beads coated with maurocalcine (left panel, +M) or with an unrelated 
peptide (right panel, Crtl). Proteins present in the void (lane V), last wash (lane LW) and bound to 
beads (lane B) were separated on a 10% SDS PAG SDS-PAG and detected by autoradiography. 
Panel C:  co-immunorpecipitation experiments were performed on solubilized SR vesicles as 
described in the methods section. Left panel: solubilized SR proteins were incubated with protein-A 
Sepharose beads coated with anti-SRP-27 Ab; right panel: solubilized SR proteins were incubated 
with protein-G Sepahrose beads coated with anti –RyR Abs. Proteins present in the void (lane 1), 
last wash (lane 2) or bound to the beads (lane 3), were separated on a 6 % SDS PAG (left) or 10 % 
SDS PAG (right), blotted onto nitrocellulose and probed with the indicated antibody.
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Fig. 1 
 
Rabbit pep.  MELLLSALSLGELALSFSR 
Mouse 1 MDLM-SALSLGELALSFSRVPLFPVFDLSYFIVSIIYLKYEPGAVELSRRHPVASWLCAM 
rat 1 MDLI-SSLSLGELALSFSRVPLFPVFDLSYFIVSIIYLKYEPGSVELSRRHPVASWLCAM 
human 1 MELL-SALSLGELALSFSRVPLFPVFDLSYFIVSILYLKYEPGAVELSRRHPIASWLCAM 
 
mouse 60 LHCFGSYILADLLLGEPIIDYFSNSSSILLASGVWYLIFFCPLDLFYKCVCFLPVKLIFV 
rat 60 LHCFGSYILADLLLGEPIIDYFSNSSSILLASGVWYLIFFCPLDLFYKCVCFLPVKLIFV 
human 60 LHCFGSYILADLLLGEPLIDYFSNNSSILLASAVWYLIFFCPLDLFYKCVCFLPVKLIFV 
 
mouse 121 AMKEVVRVRKIAVGIHHAHHHYHHGWFIMIATGWVKGSGVALLSNVEQLLRGVWKPETNE 
rat 121 AMKEVVRVRKIAVGIHHAHH-YHHGWFIMIATGWVKGSGVALLSNLEQLLRGVWKPETNE 
human 121 AMKEVVRVRKIAVGIHHAHHHYHHGWFVMIATGWVKGSGVALMSNFEQLLRGVWKPETNE 
 
mouse 180 ILHMSFPTKASLYGAILFTLQQTRWLPVSKASLIFVFTMFMVSCKVFLTATHSHSSPFDI 
rat 179 ILHMSFPTKASLYGAILFTLQQTRWLPVSKASLIFVFTMFMVSCKVFLTATHSHSSPFDV 
human 180 ILHMSFPTKASLYGAILFTLQQTRWLPVSKASLIFIFTLFMVSCKVFLTATHSHSSPFDA 
 
mouse 240 LEGYICPVLFGATWGGDHHHDNHGAPH-GMGLGTQHSSLPAKAKEELGEGSRKKKTKKAD 
rat 239 LEGYICPVLFGATWGGDHHHDNHGAPH-GMGLGTQHSGLPAKAKEELSEGFRKKKTKKAD 
human 240 LEGYICPVLFGSACGGDHHHDNHGGSHSGGGPGAQHSAMPAKSKEELSEGSRKKKAKKAD 
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Supplementary figure 1: Part of the rat SRP-27 ORF sequence was amplified by PCR using the 
following forward and reverse primers, 5'-GGGATCCAGATTGCTGTGGGTATC-3' and 
5'-CCTCGAGCCCAGTGGATCGATCCCT-3' respectively (30 cycles; 65°C; 1 min15s). The 
EcoRI and XhoI restriction enzyme sequences were added to clone the PCR product in pGEX-5X-3 
vector. GST-fusion protein was produced as previously described (19). 100 µg of recombinant 
fusion protein were used to immunize a New Zealand White rabbit. Polyclonal IgGs were purified 
from the serum using protein G-Sepharose. Bold line in the cartoon indicates the polypeptide 
sequence used as antigen. Left panel shows Ponceau red staining of mouse (M) and rat (R) total 
sarcoplasmic reticulum proteins; central panels show immunoblot with polyclonal anti-SRP-27 Ab. 
Lanes 1 and 2 show immunoblot with polyclonal Ab pre-adsorbed with GST alone (lane 1, no 
change in immunoreactivity) or anti-SRP-27 after pre-adsorption of Ab with the GST-SRP-27 
fusion protein (lane 2).
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Supplementary figure 2: Double-labeling of SRP-27 with DHPR and RyR in cultured mouse 
myotubes. SRP-27 immunolabel is strongest in the center of the myotubes (red), whereas the two 
triad proteins predominantly stain clusters in the periphery (green). SRP-27 accumulates in between 
the nuclei (arrows) and labels the nuclear envelope (arrowheads). N, examples of nuclei; bar, 10 
µm. 
